Results

eNauka >  Results >  APOLLO: Phase 3 randomized study of subcutaneous Daratumumab plus Pomalidomide and Dexamethasone (D-Pd) versus Pomalidomide and Dexamethasone (Pd) alone in patients with Relapsed/Refractory Multiple Myeloma (RRMM)
Title: APOLLO: Phase 3 randomized study of subcutaneous Daratumumab plus Pomalidomide and Dexamethasone (D-Pd) versus Pomalidomide and Dexamethasone (Pd) alone in patients with Relapsed/Refractory Multiple Myeloma (RRMM)
Authors: Einsele, H; ...; Bila, Jelena S  ; ...; (broj, koautora 23)
Issue Date: 2021
Publication: ONCOLOGY RESEARCH AND TREATMENT
ISSN: 2296-5270 Oncology Research and Treatment Search Idenfier
Type: Conference Paper
Collation: vol. 44 str. 178-178
WoS-ID: 000760622600326
URI: https://enauka.gov.rs/handle/123456789/823634
Metadata source: (Preuzeto iz Nasi u WoS)
M-category: 
Mp. category will be shown later

Find the DOI


Google ScholarTM

Items in eNauka are protected by copyright, with all rights reserved, unless otherwise indicated.